The present invention is directed to transcutaneous electrical nerve stimulation (TENS) devices which utilize novel stimulation waveforms and novel arrangements of TENS electrodes to improve the efficiency of power consumption while enhancing therapeutic effects.

Wearable devices for providing therapy to a patient may include disposable or reusable treatment pads. The treatment pads may include electrodes and are configured to apply energy to various regions around the head and eyes. The treatment pads may provide therapy when the eyes are open or closed. The wearable device may include a battery and/or control circuitry for issuing therapy pulses through the electrodes.

In certain examples, methods and structures are directed to an apparatus having a plurality of stretchable leads, with each of the plurality of stretchable leads including an associated electrode which is to receive electrical signals generated in response to a subject-s heart and to pass the received electrical signals along a respective one of plurality of stretchable leads. The apparatus also includes a patch integrating the stretchable substrate with the plurality of stretchable leads and with the patch having an area for circuitry to reside for collecting the electrical signals passed along each of the plurality of stretchable leads, wherein each of the plurality of stretchable leads is to be on a subject side of the patch. In more particular examples, the circuitry is used to provide a multi-lead ECG based on the electrical signals.

A method for using a mask-type beauty instrument is provided. The method comprises providing a mask-type beauty instrument comprising a flexible mask and a controller, applying the flexible mask of on a user's face, and turning on the controller and selecting a function button on the controller, inputting a current to a plurality of functional layers in the flexible mask, and stimulating face skin with the current.

Apparatuses, systems and methods are provided that may include a system for patient monitoring and defibrillation. The system may include at least two defibrillation electrodes. The system may further include a first unit for physiological monitoring of a patient, including ECG monitoring circuitry for monitoring ECG of the patient. The first unit may store CPR chest compression data. The system may further include a second unit, separate from the first unit, which may communicatively couple with the first unit, for providing defibrillation pulses to the patient. The second unit may include a processor, communicatively coupled with the at least two defibrillation electrodes, for providing defibrillation pulses to the patient via the at least two defibrillation electrodes.

An electrode for stimulating a neuromuscular response includes a backing layer, an electrode layer, and a hydrogel layer, and an electrode cable configured to provide an electrical signal to the electrode. The electrode is divided into a first removable portion including a first removable activation area, a second removable portion including a second removable activation area, and a main body including a main activation area, the first removable portion is configured to separate from the second removable portion and the main body by a first perforation, and the second removable portion is configured to separate from the main body by a second perforation.

The disclosure provides systems and methods for neuromodulation using a housing that at least partially contains a stimulator assembly, wherein the stimulator assembly is configured to generate vibration by mechanical oscillation and/or using a sound wave; and wherein the vibration generated by the stimulator assembly is configured to therapeutically treat the subject by stimulating one or more nerves when the housing is placed in proximity to or on a skin surface of a subject.

Devices, systems and methods are described for providing muscle contraction stimulation therapy to treat myriad diseases, including heart failure, Type 2 diabetes, and peripheral vascular disease using a skin patch or implantable stimulator that includes a multiplicity of electrodes, a processor, a stimulation circuit, one or more sensors and programming for a patient interface unit, wherein the processor is programmed to control selection of a subset of the multiplicity of electrodes and of operation of the stimulation circuit responsive to an indication of an adverse physiologic response. The indication of patient discomfort may be determined by monitoring a physiologic parameter of the subject using the one or more sensors, by direct input from the subject via the patient interface unit programming, or a combination thereof. The devices, systems and methods also provide for automatically optimizing the stimulation parameters applied by the stimulation circuit responsive to feedback from the one or more sensors and/or by using direct input from the subject.

The present disclosure relates to methods, devices, and systems used for the treatment of and/or promoting recovery from various neurological disorders and conditions, including epilepsy and other seizure disorders and movement and other related disorders, as well as for the treatment of mood, anxiety, post traumatic stress disorder, and cognitive and behavioral disorders (collectively, neuropsychiatric disorders) via stimulation of the superficial elements of the trigeminal nerve.

Improved hydrogel configurations for use with a TTField-generating system is disclosed. Also disclosed are kits containing the improved hydrogel configurations and methods of producing and using the improved hydrogel configurations.